DOI 10.1016/j.jaccas.2026.107176
Subacute Stent Thrombosis Associated With Prasugrel Refractoriness in a Patient With Chronic ITP.
Аннотация
BACKGROUND
To our knowledge, there have been no reports of stent thrombosis due to prasugrel nonresponse in patients with immune thrombocytopenia (ITP).
CASE SUMMARY: A 66-year-old man with chronic ITP presented with an inferior ST-segment elevation myocardial infarction. The patient underwent drug-eluting stent implantation. On the sixth day, he developed recurrent chest pain. Coronary angiography revealed subacute stent thrombosis. P2Y12 reactive unit (PRU) revealed prasugrel nonresponse (PRU 274), prompting a switch to ticagrelor, which improved PRU (PRU 72). No further stent thrombosis events were observed thereafter.
DISCUSSION: This case demonstrates that stent thrombosis can occur in patients unresponsive to prasugrel and that PRU measurement may be useful even in ITP patients.
TAKE-HOME MESSAGES: In ITP patients, it is necessary to carefully balance the risk of thrombosis with the risk of bleeding. Prasugrel nonresponse may contribute to stent thrombosis, and PRU may be useful for identifying prasugrel nonresponse in patients with ITP.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.